Last reviewed · How we verify

NCT06259942

Impact of Active Heating on Maternal and Neonatal Well-being

Completed NA Last updated 14 February 2024
What this trial tests

NA trial testing İntervention 1 group (underbody heater group only) in Hypothermia in 105 participants. Completed in 22 September 2022.

Timeline
19 June 2022
Primary endpoint
20 September 2022
22 September 2022

Quick facts

Lead sponsorTC Erciyes University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposesupportive care
Enrollment105
Start date19 June 2022
Primary completion20 September 2022
Estimated completion22 September 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

TC Erciyes University

Who can join

Adults 19 to 45, female only, with Hypothermia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to determine the effects of actively warming the patient and using warmed intravenous (IV) fluid during cesarean section on maternal and infant well-being

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypothermia

Currently open trials in the same condition.

Other TC Erciyes University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06259942.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing